Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone (Pred-ART)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Institute of Tropical Medicine, Belgium
Imperial College London
European and Developing Countries Clinical Trials Partnership (EDCTP)
Department of Science and Technology, South Africa
Information provided by (Responsible Party):
Graeme Meintjes, University of Cape Town
ClinicalTrials.gov Identifier:
NCT01924286
First received: August 12, 2013
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2017
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)